Pulmonx
LUNG
102 hedge funds and large institutions have $388M invested in Pulmonx in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 47 increasing their positions, 23 reducing their positions, and 25 closing their positions.
565% more call options, than puts
Call options by funds: $11M | Put options by funds: $1.65M
104% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 23
37% more capital invested
Capital invested by funds: $283M → $388M (+$105M)
1.94% more ownership
Funds ownership: 90.25% → 92.18% (+1.9%)
12% less funds holding
Funds holding: 116 → 102 (-14)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
56% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$23.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.15M |
| 4 |
Morgan Stanley
New York
|
+$4.58M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$22.8M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$12.3M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$4.52M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$3.74M |
| 5 |
RI
RTW Investments
New York
|
-$2.32M |
LUNG Hedge Fund Activity: Q1 2023 in Review
102 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q1 2023, worth a combined $388M — up 37% from $283M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of LUNG and 11 opened new positions — a net loss of 14 holders — while 23 trimmed existing stakes and 47 added.
The largest buyer was Deerfield Management, opening a new position worth an estimated $23.7M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $22.8M sold.
- 102 institutional investors held Pulmonx (LUNG) as of Q1 2023, down from 116 in Q4 2022.
- Funds reported $388M of Pulmonx stock for Q1 2023, up 37% quarter-over-quarter.
- 11 funds opened new Pulmonx positions in Q1 2023 and 25 closed out, a net change of -14 holders.
- The largest Pulmonx buyer in Q1 2023 was Deerfield Management, an estimated $23.7M added.
- The largest Pulmonx seller in Q1 2023 was Champlain Investment Partners, an estimated $22.8M sold.
Based on aggregated 13F filings for Q1 2023.